M/23/034 – PCI/Certain Assets of Wasdell

Transaction details

The proposed acquisition by Millmount Healthcare Limited (t/a PCI Pharma Services) of certain assets of Wasdell Europe Limited has been notified to the Competition and Consumer Protection Commission.

Notification date Decision date
Monday June 17, 2024
Parties Involved Business activities
Wasdell Europe Limited

Wasdell Europe Limited ("Wasdell") offers supply chain services in respect of pharmaceutical products. Wasdell operates across multiple sites in Europe and ships to over 47 countries globally.

PCI Pharma Services Group

Millmount Healthcare Limited is a company in the PCI Pharma Services Group ("PCI Group"). PCI Group is a contract development and manufacturing organisation ("CDMO") which is headquartered in Pennsylvania, USA, and operates globally. PCI Group offers the full suite of drug development and manufacturing services to the pharmaceutical industry. In the State, PCI Group offers CDMO services from two good manufacturing practices (GMP) facilities located in Drogheda, County Louth, and Stamullen, County Meath.

Economic sector Media merger
Pharmaceuticals No
Submissions from third parties due by:
Phase 1 Phase 2
Monday, July 1, 2024
Current status: Active
Simplified Merger Notification
Authorised Officer Assigned Contact Details
Louis O'Carroll

louisocarroll@ccpc.ie

Media enquiries: communications@ccpc.ie

Return to Merger Notifications

Haven’t found what you’re looking for?